Upexi (NASDAQ:UPXI) Raised to "Sell" at Wall Street Zen

Key Points

• Wall Street Zen upgraded Upexi from “strong sell” to “sell”, signaling a slightly less bearish view on the stock.
• Other analyst sentiment is mixed but leans positive overall: Cantor Fitzgerald rates Upexi strong-buy, and MarketBeat shows an average rating of Moderate Buy with a $8.33 target price.
• Upexi’s recent fundamentals remain weak, with the company reporting a loss of $2.94 per share on revenue of $10.96 million, while the stock traded at $1.38 and has a market cap of about $92.35 million.

Upexi (NASDAQ:UPXI - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "strong sell" rating to a "sell" rating in a note issued to investors on Sunday.

A number of other analysts have also weighed in on UPXI. Cantor Fitzgerald raised shares of Upexi to a "strong-buy" rating in a research report on Thursday, April 9th. iA Financial set a $8.00 target price on Upexi in a research report on Tuesday, January 13th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $8.33.

Upexi Stock Performance

NASDAQ:UPXI opened at $1.38 on Friday. The company has a debt-to-equity ratio of 2.96, a quick ratio of 2.19 and a current ratio of 2.20. The stock's fifty day moving average is $1.11 and its 200 day moving average is $1.95. The firm has a market capitalization of $92.35 million, a PE ratio of -0.43 and a beta of -0.32. Upexi has a fifty-two week low of $0.54 and a fifty-two week high of $15.50.

Upexi (NASDAQ:UPXI - Get Free Report) last posted its quarterly earnings data on Tuesday, February 10th. The company reported ($2.94) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by ($2.86). The firm had revenue of $10.96 million for the quarter, compared to the consensus estimate of $9.42 million. Upexi had a negative net margin of 496.86% and a negative return on equity of 41.47%.

Institutional Trading of Upexi

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Ameritas Advisory Services LLC purchased a new position in shares of Upexi in the 3rd quarter valued at $26,000. Clearstead Advisors LLC purchased a new stake in shares of Upexi during the 4th quarter worth $27,000. Price T Rowe Associates Inc. MD purchased a new stake in shares of Upexi during the 4th quarter worth $35,000. Belpointe Asset Management LLC bought a new stake in Upexi during the third quarter valued at about $58,000. Finally, Arkadios Wealth Advisors purchased a new position in Upexi in the third quarter valued at about $58,000. Institutional investors own 5.68% of the company's stock.

About Upexi

Upexi NASDAQ: UPXI is a full-service digital consultancy that partners with brands to design, develop, and deploy digital products and marketing strategies. The company's expertise spans user experience and interface design, custom software engineering, and data-driven marketing services. By integrating research, creative design, and technical execution, Upexi helps clients accelerate product development cycles and optimize their digital presence.

The firm serves a diverse, global clientele across sectors such as e-commerce, software-as-a-service (SaaS), healthcare, and finance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.